MMJ Recs

JUNE 23, 2024

Medicinal cannabis laws across the United States have been evolving over the years with many states creating a medicinal marijuana program for qualified patients. However, understanding the process of obtaining a medical marijuana card is different and varies from state to state.

Conditions 52

Conditions Marijuana Patients Chronic Pain 52

MMJ Recs

FEBRUARY 21, 2020

Medical marijuana, along with other cannabis products, is growing in popularity across the country. As a result, people are becoming more and more curious about the natural compounds found in marijuana and how it may be able to help them. CBD (cannabidiol) is a chemical compound derived from the marijuana or hemp plant.

CBD 59

CBD Marijuana THC Chronic Pain 59

Canna Care Docs

JUNE 22, 2023

We’ll break down all the details you need to know before starting your medical marijuana card application. Who qualifies for medical cannabis in Nevada? As in most other states, residents must be diagnosed with one or more qualifying medical conditions in order to become medical marijuana cardholders.

Marijuana 52

Marijuana Conditions Dispensary Chronic Pain 52

MMJ Recs

APRIL 15, 2022

Missouri’s medical marijuana (MMJ) program has been going from strength to strength since 2018. Having a valid Missouri MMJ card guarantees you legal and safe access to medical cannabis products to help manage or treat your symptoms. MMJ can ease or relieve the symptoms of numerous medical conditions.

Patients 52

Patients Chronic Pain Conditions Dispensary 52

Cannabis Law Report

JANUARY 30, 2019

To expand the number of manufacturers, the Drug Enforcement Administration (DEA) submitted a notice in the Federal Register on August 11, 2016, soliciting applications for licenses to manufacture marijuana for research purposes. However, over two years have passed without any new schedule I marijuana manufacturer registrations.

Research and Development 63

Research and Development DEA CBD Law 63

Veriheal

NOVEMBER 7, 2024

Department of Justice (DOJ) put forth a proposal to reclassify “marijuana” (the legal term for cannabis plants and their products with over 0.3% The DOJ’s proposal to reclassify “marijuana” products from the list of Schedule I substances to Schedule III indicates a remarkable change in U.S. government’s stance on cannabis prohibition.

DEA 97

DEA Policy Chronic Pain Marijuana 97